タルチレリン。タルチレリン水和物
WordNet
- any compound that contains water of crystallization
- become hydrated and combine with water
- cause to be hydrated; add water or moisture to; "hydrate your skin"
- supply water or liquid to in order to maintain a healthy balance; "the bicyclists must be hydrated frequently"
- small tubular solitary freshwater hydrozoan polyp
- trouble that cannot be overcome by a single effort because of its many aspects or its persistent and pervasive quality; "we may be facing a hydra that defies any easy solution"
PrepTutorEJDIC
- 含水化合物,水化物 / 〈化合物〉‘を'水和させて水化物を作る
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- [A case of 77-year-old male with spinocerebellar ataxia type 31 with left dominant dystonia].
- Saito R1, Kikuno S, Maeda M, Uesaka Y, Ida M.
- Rinshō shinkeigaku = Clinical neurology.Rinsho Shinkeigaku.2014;54(8):643-7.
- We report on the case of a 77-year-old male with genetically proven spinocerebellar ataxia type 31 (SCA31) who had dystonia. He was referred to our hospital for evaluation following a 6-year history of slowly progressive unsteadiness of his left leg during walking and dysarthria at the age of 62 yea
- PMID 25142535
- Thyrotropin-releasing hormone receptor type 1 (TRH-R1), not TRH-R2, primarily mediates taltirelin actions in the CNS of mice.
- Thirunarayanan N1, Nir EA, Raaka BM, Gershengorn MC.
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.Neuropsychopharmacology.2013 May;38(6):950-6. doi: 10.1038/npp.2012.256. Epub 2012 Dec 11.
- Thyrotropin-releasing hormone receptor type 2 (TRH-R2), not TRH-R1, has been proposed to mediate the CNS effects of TRH and its more effective analog taltirelin (TAL). Consistent with this idea, TAL exhibited higher binding affinity and signaling potency at mouse TRH-R2 than TRH-R1 in a model cell s
- PMID 23303050
- Secondary amenorrhea in a woman with spinocerebellar degeneration treated with thyrotropin-releasing hormone: a case report and in vitro analysis.
- Kanasaki H1, Oride A, Mijiddorj T, Purwana I, Miyazaki K.
- Journal of medical case reports.J Med Case Rep.2011 Dec 9;5:567. doi: 10.1186/1752-1947-5-567.
- INTRODUCTION: While thyrotropin-releasing hormone is known to be a prolactin-release stimulating factor, thyrotropin-releasing hormone-tartrate and its derivative, taltirelin hydrate, are used for the treatment of spinocerebellar degeneration, a degenerative disease characterized mainly by motor ata
- PMID 22152284
Japanese Journal
- 左右差の強い下肢ジストニアをみとめたspinocerebellar ataxia type 31(SCA31)の1例
- Taltirelin Improves Motor Ataxia Independently of Monoamine Levels in Rolling Mouse Nagoya, a Model of Spinocerebellar Atrophy(Pharmacology)
- 音声解析をもちいた脊髄小脳変性症の定量的機能評価法について : Machado-Joseph 病における taltirelin hydrate の効果
★リンクテーブル★
[★]
- 英
- taltirelin
- 化
- タルチレリン水和物 taltirelin hydrate
- 商
- セレジスト
- 関
- 脊髄小脳変性症。その他の中枢神経系用薬
[★]
- 関
- hydration、water supply
[★]
タルチレリン
- 関
- taltirelin hydrate
[★]
ヒドラ
- 関
- Hydra